Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 5,977  64.00  1.06%   
About 61% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Raymond James Associates Boosts Position in Teva Pharmaceutical Industries Limited - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Trading Down 5.3 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Teva and Viatris revives chance to dispute JJs schizophrenia drug patent - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Schechter Investment Advisors LLC Makes New Investment in Teva Pharmaceutical Industries Limited - D...
Google News at Macroaxis
over six months ago at news.google.com         
Short Interest in Teva Pharmaceutical Industries Limited Decreases By 28.9 percent - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Acquired by Wellington Management Group LLP - MarketBe...
Google News at Macroaxis
over six months ago at news.google.com         
Institutional investors have a lot riding on Teva Pharmaceutical Industries Limited with 67 percent ...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Potential Outweighs Concerns - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
American Century Companies Inc. Has 14.77 Million Holdings in Teva Pharmaceutical Industries Limited...
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Sets New 12-Month High at 13.93 - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Insights Into the Generic Drugs Market in Canada, 2024-2032, Featuring Apotex, Mylan Pharmaceuticals...
Google News at Macroaxis
over six months ago at news.google.com         
Premarket Mover Teva Pharmaceutical Industries Ltd Down 0.60 percent - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Sold by Deutsche Bank AG - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Teva Pharmaceutical Industries Limited Stock Holdings Lifted by Public Sector Pension Investment Boa...
Google News at Macroaxis
over six months ago at news.google.com         
Legal General Group Plc Has 35.71 Million Holdings in Teva Pharmaceutical Industries Limited - Defen...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites